Stifel Financial Corp Acumen Pharmaceuticals, Inc. Transaction History

Stifel Financial Corp

  • $93.7 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$2.14 - $4.01 $2,140 - $4,010
-1,000 Reduced 6.83%
13,650 $33,000
Q1 2024

May 13, 2024
SELL
$2.97 - $4.64 $4,455 - $6,959
-1,500 Reduced 9.29%
14,650 $59,000
Q4 2023

Feb 12, 2024
BUY
$1.86 - $4.48 $30,039 - $72,352
16,150 New
16,150 $62,000

Others Institutions Holding ABOS

# of Institutions
81
Shares Held
40.6M
Call Options Held
28.6K
Put Options Held
76.4K
View Full List

About Acumen Pharmaceuticals, Inc.

ABOS Quotes by TradingView
  • Ticker ABOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,503,100
  • Market Cap $58.7M
  • Description
  • Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...
More about ABOS
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email